Kyverna Therapeutics (KYTX) Retained Earnings (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Retained Earnings of -$464.6 million for Q1 2026, down 9.36% on a QoQ basis from -$424.8 million in Q4 2025, and down 50.77% year-over-year from -$943.7 million in Q1 2025.
Kyverna Therapeutics (KYTX) Retained Earnings (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Retained Earnings history runs 4 years deep, the most recent figure standing at -$464.6 million for Q1 2026.
- Quarterly Retained Earnings fell 50.77% year-over-year to -$464.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$464.6 million (down 50.77% YoY) and the FY2025 annual result came in at -$424.8 million, down 61.21% from the prior year.
- Retained Earnings was -$464.6 million for Q1 2026 at Kyverna Therapeutics, down from -$424.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$1000.0 in Q1 2024 and bottomed at -$464.6 million in Q1 2026.
- A 4-year average of -$256.0 million and a median of -$285.8 million in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2025 — Retained Earnings sank 30815400.0% — and 2026, when it sank 50.77%.
- Kyverna Therapeutics' Retained Earnings stood at -$136.0 million in 2023, then tumbled by 93.7% to -$263.5 million in 2024, then sank by 61.21% to -$424.8 million in 2025, then retreated by 9.36% to -$464.6 million in 2026.
- Business Quant data shows KYTX's Retained Earnings at -$464.6 million in Q1 2026, -$424.8 million in Q4 2025, and -$387.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Kyverna Therapeutics | 440.57 Mn | 440.57 Mn | - | -464.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -464.60 Mn |
| Dec 31, 2025 | -424.83 Mn |
| Sep 30, 2025 | -387.00 Mn |
| Jun 30, 2025 | -350.24 Mn |
| Mar 31, 2025 | -308.16 Mn |
| Dec 31, 2024 | -263.52 Mn |
| Sep 30, 2024 | -226.00 Mn |
| Jun 30, 2024 | -37,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -136.04 Mn |